KPIs & Operating Metrics(New)
Growth Metrics

Xylem (XYL) Cost Of Revenue (2016 - 2025)

Xylem filings provide 17 years of Cost of Revenue readings, the most recent being $1.3 billion for Q1 2026.

  • For the quarter ending Q1 2026, Cost of Revenue rose 1.61% year-over-year to $1.3 billion, compared with a TTM value of $5.6 billion through Mar 2026, up 3.93%, and an annual FY2025 reading of $5.6 billion, up 3.93% over the prior year.
  • Cost of Revenue hit $1.3 billion in Q1 2026 for Xylem, down from $1.5 billion in the prior quarter.
  • The five-year high for Cost of Revenue was $1.5 billion in Q4 2025, with the low at $805.0 million in Q1 2022.
  • Median Cost of Revenue over the past 5 years was $1.3 billion (2023), compared with a mean of $1.2 billion.
  • The sharpest move saw Cost of Revenue soared 53.27% in 2023, then grew 0.61% in 2024.
  • Year by year, Cost of Revenue stood at $933.0 million in 2022, then skyrocketed by 45.98% to $1.4 billion in 2023, then rose by 2.72% to $1.4 billion in 2024, then rose by 4.72% to $1.5 billion in 2025, then fell by 9.76% to $1.3 billion in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $1.3 billion, $1.5 billion, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.